Patents by Inventor David Alan Yeandle

David Alan Yeandle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for producing crystallized pleuromutilins
    Patent number: 7556948
    Abstract: Invented are non-peptide TPO mimetics. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.
    Type: Grant
    Filed: August 7, 2003
    Date of Patent: July 7, 2009
    Assignee: Glaxo Group Limited
    Inventors: Michael John Rees, Keith Graham Robins, Anna Louisa Stefanska, Jan Edward Thirkettle, Michael Sidney Verrall, David Alan Yeandle
  • Enzymatic preparation of monic acids
    Patent number: 5726049
    Abstract: A process for the production of monic acids which comprises contacting a corresponding pseudomonic acid or an ester thereof with a hydrolase enzyme from a suitable microorganism, in particular Streptomyces sp.
    Type: Grant
    Filed: February 15, 1996
    Date of Patent: March 10, 1998
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Esme Faith Hayes, John Thomas Sime, Stefan Roland Woroniecki, David Alan Yeandle